Position
SIMPLEX TRADING, LLC in Coherus Oncology, Inc.
Back to the book · All holders of CHRS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $12K$1.42 → $1.69
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 48K | $68.2K | — | — | — | 0.0% |
| Q1 2026 | 44.4K | $75K | $1.69 | $12K | −$5.17K | 0.0% |